Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Epstein-Barr Virus Suspected as Cause of Multiple Sclerosis
FDA Extends Review Period for Gene Therapies for Beta-Thalassemia, Cerebral Adrenoleukodystrophy
MPR Weekly Dose Podcast Episode 103
Oral Formulation of Edaravone Gets Priority Review for ALS
Generic Version of Cuvposa Now Available
Fixed-Dose Combo Therapy for ALS Gets Priority Review
Dopamine Agonists, DRIs Similar for QoL in Parkinson Disease
Investigational Alzheimer Disease Treatment Granted Fast Track Status
Ravulizumab Gets Priority Review for Generalized Myasthenia Gravis
Biogen Cuts Price of Controversial Aduhelm in Half
Gene Therapy Gets Priority Review for Cerebral Adrenoleukodystrophy
Vyvgart Approved for Generalized Myasthenia Gravis
Novel Pramipexole-Rasagiline Combo Promising for Early Parkinson Disease
Ublituximab Under Review for Relapsing Forms of Multiple Sclerosis
Further Study Needed for Teriflunomide in Children With Relapsing MS
Rozanolixizumab Meets All Endpoints in Generalized Myasthenia Gravis Trial
Valbenazine Improves Chorea in Patients With Huntington Disease
Lyvispah Oral Granules Approved for Spasticity Due to Multiple Sclerosis
